BioProcess International
Biopharmaceutical, Manufacturing

The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) held its annual National Meeting in June 2024 to explore key issues in the manufacture of novel biotherapeutics and vaccines.

In the development and manufacturing of innovative biotherapeutics and vaccines, many US-based and globally acting companies can look...

SME
Biopharmaceutical, COVID-19, Manufacturing

Perhaps the biggest achievement thus far at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has been disabusing companies that are members of the Manufacturing USA innovation institute that it is smart to be “a fast second” to market.

“Nobody actually believed when we started, except apparently us naively, that...

Delaware Business Times
Bioengineering, Biopharmaceutical, Manufacturing

In the fast-moving world of biopharmaceuticals, the University of Delaware is preparing to demonstrate the importance of being NIIMBL .

Launched at UD’s Delaware Biotechnology Institute last year, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is moving from its startup and...

Delaware Business Now!
Biomanufacturing, Biopharmaceutical, Education, Manufacturing

The University of Delaware plans a six-story, 200,000-square-foot research facility at the University of Delaware’s STAR Campus to house the national headquarters for the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) , slated to open in early 2020.

The groundbreaking ceremony will be on Monday, October 23rd. The...